Cargando…
Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
Mesenchymal stem cell (MSC) therapies have been used in clinical trials in various fields. These cells are easily expanded, show low immunogenicity, can be acquired from medical waste, and have multiple functions, suggesting their potential applications in a variety of diseases, including liver dise...
Autores principales: | Tsuchiya, Atsunori, Kojima, Yuichi, Ikarashi, Shunzo, Seino, Satoshi, Watanabe, Yusuke, Kawata, Yuzo, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725741/ https://www.ncbi.nlm.nih.gov/pubmed/29259715 http://dx.doi.org/10.1186/s41232-017-0045-6 |
Ejemplares similares
-
Mesenchymal Stem Cells and Induced Bone Marrow‐Derived Macrophages Synergistically Improve Liver Fibrosis in Mice
por: Watanabe, Yusuke, et al.
Publicado: (2018) -
Effects of Human Adipose Tissue-Derived and Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in a Dextran Sulfate Sodium-Induced Mouse Model
por: Ikarashi, Shunzo, et al.
Publicado: (2019) -
Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers
por: Seino, Satoshi, et al.
Publicado: (2018) -
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
por: Watanabe, Yusuke, et al.
Publicado: (2021) -
Delayed pancreatic ductal leakage after EUS-FNA for autoimmune pancreatitis
por: Ikarashi, Satoshi, et al.
Publicado: (2019)